中文 | English
Return
Total: 11 , 1/2
Show Home Prev Next End page: GO
Author:(Heejoon JANG)

2.Heart rate is associated with mortality in patients undergoing continuous renal replacement therapy.

Soojin LEE ; Yeonhee LEE ; Heejoon JANG ; Hongran MOON ; Dong Ki KIM ; Seung Seok HAN

Kidney Research and Clinical Practice 2017;36(3):250-256

4.Combi-Elastography versus Transient Elastography for Assessing the Histological Severity of Metabolic Dysfunction-Associated Steatotic Liver Disease

Yun Kyu LEE ; Dong Hyeon LEE ; Sae Kyung JOO ; Heejoon JANG ; Young Ho SO ; Siwon JANG ; Dong Ho LEE ; Jeong Hwan PARK ; Mee Soo CHANG ; Won KIM ;

Gut and Liver 2024;18(6):1048-1059

5.Combi-Elastography versus Transient Elastography for Assessing the Histological Severity of Metabolic Dysfunction-Associated Steatotic Liver Disease

Yun Kyu LEE ; Dong Hyeon LEE ; Sae Kyung JOO ; Heejoon JANG ; Young Ho SO ; Siwon JANG ; Dong Ho LEE ; Jeong Hwan PARK ; Mee Soo CHANG ; Won KIM ;

Gut and Liver 2024;18(6):1048-1059

6.Combi-Elastography versus Transient Elastography for Assessing the Histological Severity of Metabolic Dysfunction-Associated Steatotic Liver Disease

Yun Kyu LEE ; Dong Hyeon LEE ; Sae Kyung JOO ; Heejoon JANG ; Young Ho SO ; Siwon JANG ; Dong Ho LEE ; Jeong Hwan PARK ; Mee Soo CHANG ; Won KIM ;

Gut and Liver 2024;18(6):1048-1059

7.Combi-Elastography versus Transient Elastography for Assessing the Histological Severity of Metabolic Dysfunction-Associated Steatotic Liver Disease

Yun Kyu LEE ; Dong Hyeon LEE ; Sae Kyung JOO ; Heejoon JANG ; Young Ho SO ; Siwon JANG ; Dong Ho LEE ; Jeong Hwan PARK ; Mee Soo CHANG ; Won KIM ;

Gut and Liver 2024;18(6):1048-1059

8.Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study

Heejoon JANG ; Su Jong YU ; Hong Ghi LEE ; Tae Min KIM ; Yun Bin LEE ; Eun Ju CHO ; Jeong-Hoon LEE ; Jung-Hwan YOON ; Yoon Jun KIM

Journal of Korean Medical Science 2023;38(28):e216-

9.Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment

Cheol-Hyung LEE ; Yun Bin LEE ; Minseok Albert KIM ; Heejoon JANG ; Hyunwoo OH ; Sun Woong KIM ; Eun Ju CHO ; Kyung-Hun LEE ; Jeong-Hoon LEE ; Su Jong YU ; Jung-Hwan YOON ; Tae-You KIM ; Yoon Jun KIM

Clinical and Molecular Hepatology 2020;26(3):328-339

10.Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study

Seogsong JEONG ; Yun Hwan OH ; Joseph C AHN ; Seulggie CHOI ; Sun Jae PARK ; Hye Jun KIM ; Gyeongsil LEE ; Joung Sik SON ; Heejoon JANG ; Dong Hyeon LEE ; Meng SHA ; Lei CHEN ; Won KIM ; Sang Min PARK

Clinical and Molecular Hepatology 2024;30(3):487-499

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 11 , 1/2 Show Home Prev Next End page: GO